SCHEMBL6173471

SCHEMBL6173471

CC(c1ccnc2c(Cl)cccc12)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.42
LMNA P02545 1/20 0.33
NR1H2 P55055 2/20 0.33
NR1H3 Q13133 2/20 0.33
MAP4K4 O95819 1/20 0.31
CSNK2A1 P68400 1/20 0.31
HIPK4 Q8NE63 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.30
NR4A2 P43354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175238 0.91 IGF1R (0.43) IGF1RLMNAPTGDR2
SCHEMBL6176096 0.88 IGF1R (0.42) IGF1RLMNA
SCHEMBL6173570 0.86 IGF1R (0.43) IGF1RLMNA
SCHEMBL6171030 0.85 LMNA (0.40) LMNA
SCHEMBL6174980 0.85 IGF1R (0.36) IGF1RLMNANR4A2
SCHEMBL6171408 0.82 IGF1R (0.35) IGF1RLMNA
SCHEMBL6172371 0.80 IGF1R (0.45) IGF1RLMNA
SCHEMBL6169741 0.80 IGF1R (0.36) IGF1RLMNA
SCHEMBL6174189 0.80 IGF1R (0.42) IGF1RLMNA
SCHEMBL6170257 0.79 IGF1R (0.39) IGF1RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed